March 2, 2014
The Food and Drug Administration is looking for a contractor to monitor social media chatter about the drugs and other products it regulates and how that chatter shifts as a result of FDA risk warnings, solicitation documents show.
The agency is looking for a contractor that can provide historical information about the sorts of conversations consumers are having on blogs, message boards and social media sites about the product classes FDA regulates — such as drugs, medical devices, food and tobacco — and then track when the sentiment or volume of those conversations shifts, according to the sources sought notice posted on Tuesday.
FDA wants to track what makes those conversations spike, rise slowly or trend downward, the notice said, and to gather information about “about social media buzz volume over time, top sources of buzz, most popular forums of online discussion, most-cited news stories, major themes of discussion, sentiment analysis, word clouds and/or message maps, and a sample of verbatim consumer comments.”
A sources sought notice doesn’t obligate FDA to purchase any goods or services.